Currently out of the existing stock ratings of Graham Doyle, 9 are a SELL (25.71%), 15 are a HOLD (42.86%), 11 are a BUY (31.43%).

Graham Doyle

Work Performance Price Targets & Ratings Chart

Analyst Graham Doyle, currently employed at UBS, carries an average stock price target met ratio of 46.67% that have a potential upside of 25.07% achieved within 236 days.

Graham Doyle’s has documented 55 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on GEHC, GE HealthCare Technologies at 15-Jan-2026.

Wall Street Analyst Graham Doyle

Analyst best performing recommendations are on PHG (KONINKLIJKE PHILIPS NV ADR).
The best stock recommendation documented was for PHG (KONINKLIJKE PHILIPS NV ADR) at 9/2/2022. The price target of $16.49 was fulfilled within 7 days with a profit of $1.47 (9.79%) receiving and performance score of 13.98.

Average potential price target upside

SNN Smith & Nephew SNATS PHG Koninklijke Philips NV ADR FMS Fresenius Medical Care FSNUY Fresenius SE KGaA ADR ALC Alcon AG GEHC GE HealthCare Technologies

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 28-Jul-2022

$36

$-0.9 (-2.44%)

$27

6 months 13 days ago
(18-Aug-2025)

5/7 (71.43%)

$0.01 (0.03%)

416

Hold Since 12-Mar-2025

11 months 19 days ago
(12-Mar-2025)

0/3 (0%)

$-10.44 (-43.85%)

Buy Since 03-Nov-2023

$15.29

$-21.61 (-58.56%)

$15.07

2 years 4 months ago
(03-Nov-2023)

7/14 (50%)

$-7.54 (-33.03%)

673

Buy Since 14-Apr-2023

$33

$-3.9 (-10.57%)

$39.5

2 years 4 months 27 days ago
(04-Oct-2023)

2/3 (66.67%)

$10.75 (48.31%)

762

Buy Since 11-Apr-2023

$16.94

$-19.96 (-54.09%)

$14.12

2 years 10 months 20 days ago
(11-Apr-2023)

0/3 (0%)

$-10.46 (-38.18%)

Show more analysts

Please expand the browser size to see the chart

Which stock is Graham Doyle is most bullish on?

Potential upside of $-7.27 has been obtained for GEHC (GE HEALTHCARE TECHNOLOGIES)

What Year was the first public recommendation made by Graham Doyle?

On 2022

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?